Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.,Journal of Antimicrobial Chemotherapy

当前位置： X-MOL 学术 › J. Antimicrob. Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
Journal of Antimicrobial Chemotherapy ( IF 3.9 ) Pub Date : 2020-06-17 , DOI: 10.1093/jac/dkaa212
Karin Meinike Jørgensen ₁ , Jesus Guinea _{2,

3} , Joseph Meletiadis ₄ , Rasmus Krøger Hare ₁ , Maiken Cavling Arendrup _{1,

5,

6}

Affiliation

EUCAST recently revised the definition of the ‘I’ category from ‘intermediate’ to ‘susceptible, increased exposure’. Consequently, all current antifungal breakpoints have been reviewed and revised breakpoints (v 10.0) have been released.

中文翻译：